Ajanta Pharma USA Inc. till date has received twenty ANDA final approvals and four ANDA tentative approvals from US Food and Drug Administration (FDA).

Currently, fifteen ANDAs are under review with the FDA.

Ajanta is poised to submit over ten to twelve ANDAs annually, ensuring a strong, consistent pipeline to fuel growth.

For list of products click here